Prevalence of obesity-related multimorbidity and its health care costs among adults in the United States
The prevalence of obesity-related multimorbidity increased with increasing weight classes within age groups. Obesity-related multimorbidity presented at an earlier age with higher weight class, such that the predicted probability of having obesity-related multimorbidity was more than a decade younger in class 2 and class 3 obesity compared with overweight. It was associated with increased HCRU and higher-than-expected costs exceeding the sum for the ORCs. Early diagnosis and treatment of obesity may be needed to prevent or delay the onset of obesity-related multimorbidity and limit its associated health care costs.
Authors
- Clare J. Lee (ORCID: https://orcid.org/0000-0002-0824-0207)
- Gerhardt Pohl
- Julia P. Dunn (ORCID: https://orcid.org/0000-0001-9561-0183)
- Xiaohong Li (ORCID: https://orcid.org/0000-0003-0336-7302)
- Hui Wang (ORCID: https://orcid.org/0000-0002-7639-5702)
- Kyrian Ezendu
Institutions
- Eli Lilly (United States) (US)
Publication Details
- Journal
- Journal of Managed Care & Specialty Pharmacy
- Published
- 2025-02-01
- DOI
- https://doi.org/10.18553/jmcp.2025.31.2.179
- Citations
- 4
- Primary Topic
- Chronic Disease Management Strategies
- Type
- article
- Field-Weighted Citation Impact
- 5.42